Trial Profile
Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling study of risperidone in Chinese schizophrenia patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Mar 2016
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics; Pharmacokinetics
- 28 Mar 2016 New trial record
- 23 Mar 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics